Evaluation of serum miR-221/222 as novel tumor markers

ABSTRACT: Primary outcome(s): Presence of colorectal adenoma or gastrointestinal cancers

DISEASE(S): Esophageal Cancer, Gastric Cancer, Colorectal Cancer, Pancreatic Cancer, Bile Duct Cancer, And Healthy Controls

PROVIDER: 2630284 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR